Alvogen’s operations in Poland started in July 2011. The office is situated in Warsaw, capital of Poland. Dariusz Glogowski is the country manager for Alvogen Poland. Dariusz has a strong background of 20 years in the pharmaceutical industry. The office currently has 12 employees together with Regulatory & Pharmacovigilance expert, Sales & Marketing Manager, experienced hospital key accounts, person responsible for tenders, Finance and Administration Manager and Office Assistant. The local team is well positioned to build Alvogen presence in Poland, leveraging on a strong global product pipeline.
With 38 million inhabitance, Poland is 3rd biggest population in CEE (after Russia and Ukraine). At around 11.8 billion USD market, Poland is second biggest pharmaceutical market in CEE (after Russia).
Polish pharmaceutical market is covered mostly with generics – 80% volume, but they represent less than 30% of the value of drugs sold. Total yearly healthcare costs are calculated as 35 billion USD (7% GDP). There are approximately 80.000 doctors, 180.000 nurses and over 20.000 pharmacists working in Polish healthcare system.